1. Zhao, Yue, Wang, Yimin, Zhu, Fudi, Ma, Xiao, Zhang, Dongwei. 2020. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients. In Clinical and experimental medicine, 20, 249-259. doi:10.1007/s10238-019-00604-4. https://pubmed.ncbi.nlm.nih.gov/31980982/
2. Huang, Qian-Rong, Jiang, Qian, Tan, Ju-Yuan, Deng, Teng, Gong, Yi-Zhen. 2024. The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort. In Frontiers in pharmacology, 15, 1390615. doi:10.3389/fphar.2024.1390615. https://pubmed.ncbi.nlm.nih.gov/38698811/
3. Zhu, Zhonglin, Li, Minghan, Weng, Junyong, Guo, Yang, Xu, Ye. 2024. LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3. In Cancer letters, 589, 216828. doi:10.1016/j.canlet.2024.216828. https://pubmed.ncbi.nlm.nih.gov/38521199/
4. Liang, Zhuangzhuang, Yang, Jian, Wang, Jiajia, Jiang, Feng, Ma, Jie. 2022. Systematic analysis of MCM3 in pediatric medulloblastoma via multi-omics analysis. In Frontiers in molecular biosciences, 9, 815260. doi:10.3389/fmolb.2022.815260. https://pubmed.ncbi.nlm.nih.gov/36133906/
5. Chen, Yi, Li, Liu-Yan, Li, Jian-Di, Chen, Gang, Wei, Dan-Ming. 2024. Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry. In Annals of medicine, 56, 2405879. doi:10.1080/07853890.2024.2405879. https://pubmed.ncbi.nlm.nih.gov/39310930/
6. Tímár, József, Gyorffy, Balázs, Rásó, Erzsébet. 2010. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? In Clinical & experimental metastasis, 27, 371-87. doi:10.1007/s10585-010-9307-2. https://pubmed.ncbi.nlm.nih.gov/20177751/
7. Li, Hong-Tao, Wei, Bing, Li, Zhou-Quan, Zhang, Qin-Le, Yang, Xiao-Li. 2020. Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma. In Oncology letters, 20, 308. doi:10.3892/ol.2020.12171. https://pubmed.ncbi.nlm.nih.gov/33093917/
8. Kang, Eun Young, Millstein, Joshua, Popovic, Gordana, Kelemen, Linda E, Köbel, Martin. 2021. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. In Virchows Archiv : an international journal of pathology, 480, 855-871. doi:10.1007/s00428-021-03232-0. https://pubmed.ncbi.nlm.nih.gov/34782936/
9. Yamamoto, M, Tamura, K, Hiratsuka, K, Abiko, Y. . Stimulation of MCM3 gene expression in osteoblast by low level laser irradiation. In Lasers in medical science, 16, 213-7. doi:. https://pubmed.ncbi.nlm.nih.gov/11482820/
10. Ma, Hui, Liu, Zhen, Li, Honglin, Qu, Pengpeng, Wang, Yuquan. 2021. Bioinformatics Analysis Reveals MCM3 as an Important Prognostic Marker in Cervical Cancer. In Computational and mathematical methods in medicine, 2021, 8494260. doi:10.1155/2021/8494260. https://pubmed.ncbi.nlm.nih.gov/34671420/